Nilotinib With Chemotherapy for the Treatment of Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia (ALLPhi)

This study has been terminated.
(The study was terminated due to excessive toxicity and low compliance to the protocol scheme.)
Information provided by (Responsible Party):
Rony Schaffel, Universidade Federal do Rio de Janeiro Identifier:
First received: May 15, 2009
Last updated: July 7, 2015
Last verified: July 2015
No Study Results Posted on for this Study
  Study Status: This study has been terminated.
  Estimated Study Completion Date: July 2015
  Primary Completion Date: June 2012 (Final data collection date for primary outcome measure)